Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Debt Ratio (2016 - 2025)

Guided Therapeutics' Debt Ratio history spans 14 years, with the latest figure at 0.05 for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 62.15% to 0.05 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.05, a 62.15% decrease, with the full-year FY2025 number at 0.05, down 62.15% from a year prior.
  • Debt Ratio hit 0.05 in Q4 2025 for Guided Therapeutics, down from 0.12 in the prior quarter.
  • Over the last five years, Debt Ratio for GTHP hit a ceiling of 0.95 in Q2 2024 and a floor of 0.01 in Q3 2022.
  • Historically, Debt Ratio has averaged 0.24 across 4 years, with a median of 0.11 in 2025.
  • Biggest five-year swings in Debt Ratio: tumbled 98.64% in 2021 and later soared 1160.02% in 2022.
  • Tracing GTHP's Debt Ratio over 4 years: stood at 0.05 in 2021, then crashed by 44.9% to 0.03 in 2022, then surged by 303.04% to 0.12 in 2024, then crashed by 62.15% to 0.05 in 2025.
  • Business Quant data shows Debt Ratio for GTHP at 0.05 in Q4 2025, 0.12 in Q3 2025, and 0.1 in Q2 2025.